|
Variable
|
Total
|
Vaccinated
|
Non-vaccinated
|
P-value
|
|
Seroconverted
(>10 IU/L)
|
Non-responder
(<10 IU/L)
|
|
Cohort
|
| Total cohort |
345 |
223 (64.6%) |
117 (33.9%) |
5 (1.5%) |
|
| 2015 |
52 |
52 (100.0%) |
0 |
No record |
|
| 2016 |
80 |
52 (65.0%) |
26 (32.5%) |
2 (2.5%) |
|
| 2017 |
116 |
59 (50.9%) |
54 (46.5%) |
3 (2.6%) |
|
| 2018 |
97 |
60 (61.9%) |
37 (38.1%) |
0 |
|
|
Gender
|
| Male |
121 |
75 (62.0%) |
45 (37.2%) |
1 (0.8%) |
|
| Female |
224 |
144 (64.3%) |
76 (33.9%) |
4 (1.8%) |
0.298 |
|
Ethnicity
|
| Chinese |
214 |
149 (69.6%) |
63 (29.4%) |
2 (0.9%) |
|
| Malay |
68 |
32 (47.1%) |
35 (51.5%) |
1 (1.5%) |
|
| Indian |
63 |
43 (68.2%) |
18 (28.6%) |
2 (3.2%) |
0.002 |